Effects of electroconvulsive shock on the phosphorylation of DARPP-32 in rat striatum

Psychiatry Research

Volumn 170, Issue 1, 2009, Pages 91-95

  Park, Hye Jean ^a   Cui, Feng Ji ^b   Roh, Jae Woo ^a   Jung, Young Chul ^a   Kim, Se Hyun ^a   Kim, Yong Sik ^a   Kang, Ung Gu ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

DARPP 32; Electroconvulsive shock; Protein kinase A; Protein phosphatase 1; Striatum

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE 1; SERINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROCONVULSIVE THERAPY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; THERAPY EFFECT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CORPUS STRIATUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ELECTROSHOCK; MALE; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 70350025542     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.07.002     Document Type: Article

References (29)

1. Albert K.A., Hemmings Jr. H.C., Adamo A.I., Potkin S.G., Akbarian S., Sandman C.A., Cotman C.W., Bunney Jr. W.E., and Greengard P. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Archives of General Psychiatry 59 (2002) 705-712
2. Bibb J.A., Snyder G.L., Nishi A., Yan Z., Meijer L., Fienberg A.A., Tsai L.H., Kwon Y.T., Girault J.A., Czernik A.J., Huganir R.L., Hemmings Jr. H.C., Nairn A.C., and Greengard P. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402 (1999) 669-671
3. Cummings J.L. The neuroanatomy of depression. Journal of Clinical Psychiatry 54 (1993) 14-20 Suppl
4. Desdouits F., Cheetham J.J., Huang H.-B., Kwon Y.-G., da Cruz e Sliva E.F., Denefle P., Ehrlich M.E., Nairn A.C., Greengard P., and Girault J.-A. Mechanism of inhibition of protein phosphatase 1 by DARPP-32:studies with recombinant DARPP-32 and synthetic peptides. Biochemical and Biophysical Research Communications 206 (1995) 652-658
5. DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends in Neurosciences 13 (1990) 286-289
6. Fernandez J.J., Candenas M.L., Souto M.L., Trujillo M.M., and Norte M. Okadaic acid, useful tool for studying cellular processes. Current Medicinal Chemistry 9 (2002) 229-262
7. Fochtmann L.J. Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacology Bulletin 30 (1994) 321-444
8. Greenamyre J.T., and O'Brien C.F. N-methyl-d-aspartate antagonists in the treatment of Parkinson's disease. Archives of Neurology 48 (1991) 977-981
9. Greengard P. The neurobiology of slow synaptic transmission. Science 294 (2001) 1024-1030
10. Hemmings Jr. H.C., Nairn A.C., Aswad D.W., and Greengard P. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus. Journal of Neuroscience 4 (1984) 99-110
11. Jeon S.H., Seong Y.S., Juhnn Y.S., Kang U.G., Ha K.S., Kim Y.S., and Park J.B. Electroconvulsive shock increases the phosphorylation of cyclic AMP response element binding protein at Ser-133 in rat hippocampus but not in cerebellum. Neuropharmacology 36 (1997) 411-414
12. Jeon S.H., Oh S.W., Kang U.G., Ahn Y.M., Bae C.D., Park J.B., and Kim Y.S. Electroconvulsive shock increases the phosphorylation of Pyk2 in the rat hippocampus. Biochemical and Biophysical Research Communications 282 (2001) 1026-1030
13. Kang U.G., Jeon W.J., Kim Y., Chung C.K., Park J.B., Juhnn Y.S., and Kim Y.S. Transient activation of protein phosphatase 2A induced by electroconvulsive shock in the rat frontal cortex. Neuroscience Letters 390 (2005) 171-175
14. Ma J., Ye N., and Cohen B.M. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum. Neuroscience 141 (2006) 1469-1480
15. Nath R., Davis M., Probert A.W., Kupina N.C., Ren X., Schielke G.P., and Wang K.K. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochemical and Biophysical Research Communications 274 (2000) 16-21
16. Nishi A., Snyder G.L., Nairn A.C., and Greengard P. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. Journal of Neurochemistry 72 (1999) 2015-2021
17. Nishi A., Bibb J.A., Snyder G.L., Higashi H., Nairn A.C., and Greengard P. Amplification of dopaminergic signaling by a positive feedback loop. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 12840-12845
18. Nishi A., Bibb J.A., Snyder G.L., Matsuyama S., Hamada M., Higashi H., Nairn A.C., and Greengard P. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. Journal of Neurochemistry 81 (2002) 832-841
19. Nishi A., Watanabe Y., Higashi H., Tanaka M., Nairn A.C., and Greengard P. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 1199-1204
20. Pozzi L., Hakansson K., Usiello A., Borgkvist A., Lindskog M., Greengard P., and Fisone G. Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. Journal of Neurochemistry 86 (2003) 451-459
21. Roh M.S., Kang U.G., Shin S.Y., Lee Y.H., Jung H.Y., Juhnn Y.S., and Kim Y.S. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 (2003) 1-5
22. Rosa D.V., Souza R.P., Souza B.R., Motta B.S., Caetano F., Jornada L.K., Feier G., Gomez M.V., Quevedo J., and Romano-Silva M.A. DARPP-32 expression in rat brain after electroconvulsive stimulation. Brain Research 1179 (2007) 35-41
23. Scheggi S., Raone A., De Montis M.G., Tagliamonte A., and Gambarana C. Behavioral expression of cocaine sensitization in rats is accompanied by a distinct pattern of modifications in the PKA/DARPP-32 signaling pathway. Journal of Neurochemistry 103 (2007) 1168-1183
24. Sharma P., Sharma M., Amin N.D., Albers W.A., and Pant H.C. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 11156-11160
25. Svenningsson P., Tzavara E.T., Liu F., Fienberg A.A., Nomikos G.G., and Greengard P. DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 3188-3193
26. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.L., Fienberg A.A., Nomikos G.G., and Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 302 (2003) 1412-1415
27. Svenningsson P., Nairn A.C., and Greengard P. DARPP-32 mediates the actions of multiple drugs of abuse. AAPS Journal 7 (2005) E353-360
28. Yoshida K., Higuchi H., Kamata M., Yoshimoto M., Shimizu T., and Hishikawa Y. Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry 21 (1997) 707-715
29. Yui K., Goto K., Ikemoto S., Ishiguro T., Angrist B., Duncan G.E., Sheitman B.B., Lieberman J.A., Bracha S.H., and Ali S.F. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Molecular Psychiatry 4 (1999) 512-523